Comment on

• Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.

  Bazinet M, Pântea V, Placinta G, Moscalu I, Cebotarescu V, Cojuhari L, Jimbei P, Iarovoi L, Smesnoi V, Musteata T, Jucov A, Dittmer U, Krawczyk A, Vaillant A. Bazinet M, et al. Gastroenterology. 2020 Jun;158(8):2180-2194. doi: 10.1053/j.gastro.2020.02.058. Epub 2020 Mar 6. Gastroenterology. 2020. PMID: 32147484 Clinical Trial.
• Nucleic Acid Polymer Therapy for Hepatitis B Virus: Strong Hepatitis B Surface Antigen Decline But Many Unanswered Questions.

  Sonneveld MJ, Gehring AJ, Janssen HLA. Sonneveld MJ, et al. Gastroenterology. 2021 Feb;160(3):966-967. doi: 10.1053/j.gastro.2020.06.097. Epub 2020 Aug 29. Gastroenterology. 2021. PMID: 32866506 No abstract available.